Terns Pharmaceuticals Stock Forecast - Simple Exponential Smoothing

TERN Stock  USD 4.82  0.26  5.70%   
The Simple Exponential Smoothing forecasted value of Terns Pharmaceuticals on the next trading day is expected to be 4.82 with a mean absolute deviation of  0.30  and the sum of the absolute errors of 18.03. Terns Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Terns Pharmaceuticals stock prices and determine the direction of Terns Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Terns Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Terns Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Terns Pharmaceuticals' systematic risk associated with finding meaningful patterns of Terns Pharmaceuticals fundamentals over time.
Check out Historical Fundamental Analysis of Terns Pharmaceuticals to cross-verify your projections.
To learn how to invest in Terns Stock, please use our How to Invest in Terns Pharmaceuticals guide.
  
As of the 23rd of April 2024, Inventory Turnover is likely to drop to 0.10. In addition to that, Payables Turnover is likely to drop to 0.28. As of the 23rd of April 2024, Common Stock Shares Outstanding is likely to drop to about 37.9 M. In addition to that, Net Loss is likely to drop to about (57 M).
Most investors in Terns Pharmaceuticals cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Terns Pharmaceuticals' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Terns Pharmaceuticals' price structures and extracts relationships that further increase the generated results' accuracy.
Terns Pharmaceuticals simple exponential smoothing forecast is a very popular model used to produce a smoothed price series. Whereas in simple Moving Average models the past observations for Terns Pharmaceuticals are weighted equally, Exponential Smoothing assigns exponentially decreasing weights as Terns Pharmaceuticals prices get older.

Terns Pharmaceuticals Simple Exponential Smoothing Price Forecast For the 24th of April

Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Terns Pharmaceuticals on the next trading day is expected to be 4.82 with a mean absolute deviation of 0.30, mean absolute percentage error of 0.14, and the sum of the absolute errors of 18.03.
Please note that although there have been many attempts to predict Terns Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Terns Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Terns Pharmaceuticals Stock Forecast Pattern

Backtest Terns PharmaceuticalsTerns Pharmaceuticals Price PredictionBuy or Sell Advice 

Terns Pharmaceuticals Forecasted Value

In the context of forecasting Terns Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Terns Pharmaceuticals' downside and upside margins for the forecasting period are 0.05 and 10.42, respectively. We have considered Terns Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
4.82
4.82
Expected Value
10.42
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Terns Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Terns Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria114.3376
BiasArithmetic mean of the errors 0.0088
MADMean absolute deviation0.3005
MAPEMean absolute percentage error0.0459
SAESum of the absolute errors18.03
This simple exponential smoothing model begins by setting Terns Pharmaceuticals forecast for the second period equal to the observation of the first period. In other words, recent Terns Pharmaceuticals observations are given relatively more weight in forecasting than the older observations.

Predictive Modules for Terns Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Terns Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Terns Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.244.8010.40
Details
Intrinsic
Valuation
LowRealHigh
2.147.7413.34
Details
8 Analysts
Consensus
LowTargetHigh
15.1316.6318.46
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.41-0.34-0.29
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Terns Pharmaceuticals. Your research has to be compared to or analyzed against Terns Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Terns Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Terns Pharmaceuticals.

Other Forecasting Options for Terns Pharmaceuticals

For every potential investor in Terns, whether a beginner or expert, Terns Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Terns Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Terns. Basic forecasting techniques help filter out the noise by identifying Terns Pharmaceuticals' price trends.

Terns Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Terns Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Terns Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Terns Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Terns Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Terns Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Terns Pharmaceuticals' current price.

Terns Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Terns Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Terns Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Terns Pharmaceuticals stock market strength indicators, traders can identify Terns Pharmaceuticals entry and exit signals to maximize returns.

Terns Pharmaceuticals Risk Indicators

The analysis of Terns Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Terns Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting terns stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Terns Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Terns Pharmaceuticals' short interest history, or implied volatility extrapolated from Terns Pharmaceuticals options trading.

Currently Active Assets on Macroaxis

When determining whether Terns Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Terns Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Terns Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Terns Pharmaceuticals Stock:
Check out Historical Fundamental Analysis of Terns Pharmaceuticals to cross-verify your projections.
To learn how to invest in Terns Stock, please use our How to Invest in Terns Pharmaceuticals guide.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Complementary Tools for Terns Stock analysis

When running Terns Pharmaceuticals' price analysis, check to measure Terns Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Terns Pharmaceuticals is operating at the current time. Most of Terns Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Terns Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Terns Pharmaceuticals' price. Additionally, you may evaluate how the addition of Terns Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Stocks Directory
Find actively traded stocks across global markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Money Managers
Screen money managers from public funds and ETFs managed around the world
Bonds Directory
Find actively traded corporate debentures issued by US companies
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Global Correlations
Find global opportunities by holding instruments from different markets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Is Terns Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Terns Pharmaceuticals. If investors know Terns will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Terns Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.27)
Revenue Per Share
0.035
Return On Assets
(0.23)
Return On Equity
(0.34)
The market value of Terns Pharmaceuticals is measured differently than its book value, which is the value of Terns that is recorded on the company's balance sheet. Investors also form their own opinion of Terns Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Terns Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Terns Pharmaceuticals' market value can be influenced by many factors that don't directly affect Terns Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Terns Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Terns Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Terns Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.